ID: ALA2147349

Max Phase: Preclinical

Molecular Formula: C6H9ClN2O2

Molecular Weight: 140.14

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.NCc1ccc(C(=O)O)[nH]1

Standard InChI:  InChI=1S/C6H8N2O2.ClH/c7-3-4-1-2-5(8-4)6(9)10;/h1-2,8H,3,7H2,(H,9,10);1H

Standard InChI Key:  CPVROAJAKXCAOT-UHFFFAOYSA-N

Associated Targets(non-human)

Gamma-amino-N-butyrate transaminase 192 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 140.14Molecular Weight (Monoisotopic): 140.0586AlogP: 0.17#Rotatable Bonds: 2
Polar Surface Area: 79.11Molecular Species: ZWITTERIONHBA: 2HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.44CX Basic pKa: 8.87CX LogP: -2.59CX LogD: -2.60
Aromatic Rings: 1Heavy Atoms: 10QED Weighted: 0.55Np Likeness Score: 0.18

References

1. Hawker DD, Silverman RB..  (2012)  Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase.,  20  (19): [PMID:22944334] [10.1016/j.bmc.2012.08.009]

Source